Matches in SemOpenAlex for { <https://semopenalex.org/work/W4234784734> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4234784734 endingPage "11" @default.
- W4234784734 startingPage "1" @default.
- W4234784734 abstract "ST2 is a member of the interleukin-1 receptor family, which is expressed in a trans membrane form (ST2L) as well as in a soluble secreted form [1]. Recently, soluble ST2(sST2) was found to be elevated in patients with chronic heart failure with reduced ejection fraction (HFrEF) and regarded as a promising novel biomarkers that can improve risk stratification [2, 3]. In 2012, Broch K et al. showed that baseline sST2 was associated with death due to worsening heart failure (HF), hospitalization due to worsening HF, and all cardiovascular hospitalization in older patients with ischemic HF[4]. In a multicenter study enrolled 447 patients with acutely decompensated heart failure, sST2 was an independent predictor of mortality for 1 year follow-up, regardless of the left ventricular ejection fraction[5]. As a β-galactoside-binding lectin secreted by activated macrophages, galectin-3 (Gal-3) exists in the cytoplasm and in a secreted form, and is involved in several physiological and pathological processes that contribute to HF, including myocardial fibrosis, inflammation and cardiac remodeling [6-8]. Sub study of RELAX trial suggested that Gal-3 levels were associated with severity of renal dysfunction. De Boer et al. found that Gal-3 is an independent marker for composite end of all-cause mortality and HF hospitalization in HF and appears to be more powerful in patients with heart failure with preserved ejection fraction (HFpEF)[9]. According to results from the Aldo-DHF trial, plasma Gal-3 in HFpEF was associated with adverse outcome, independent of treatment or NT-proBNP [10]." @default.
- W4234784734 created "2022-05-12" @default.
- W4234784734 date "2020-03-24" @default.
- W4234784734 modified "2023-09-26" @default.
- W4234784734 title "Are Plasma ST2 and Galectin-3 Predictors for Clinical Outcomes After Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy?" @default.
- W4234784734 cites W1506577935 @default.
- W4234784734 cites W1832828081 @default.
- W4234784734 cites W1893887535 @default.
- W4234784734 cites W1969343364 @default.
- W4234784734 cites W1973219094 @default.
- W4234784734 cites W1976828141 @default.
- W4234784734 cites W1989352782 @default.
- W4234784734 cites W1994391038 @default.
- W4234784734 cites W1998117193 @default.
- W4234784734 cites W2002114555 @default.
- W4234784734 cites W2002378169 @default.
- W4234784734 cites W2015404118 @default.
- W4234784734 cites W2027560922 @default.
- W4234784734 cites W2029909301 @default.
- W4234784734 cites W2033967875 @default.
- W4234784734 cites W2047273318 @default.
- W4234784734 cites W2071962149 @default.
- W4234784734 cites W2085720683 @default.
- W4234784734 cites W2091173764 @default.
- W4234784734 cites W2094188666 @default.
- W4234784734 cites W2097618980 @default.
- W4234784734 cites W2101099004 @default.
- W4234784734 cites W2109560166 @default.
- W4234784734 cites W2117817928 @default.
- W4234784734 cites W2123094296 @default.
- W4234784734 cites W2130306608 @default.
- W4234784734 cites W2138790009 @default.
- W4234784734 cites W2139571734 @default.
- W4234784734 cites W2152070471 @default.
- W4234784734 cites W2490047585 @default.
- W4234784734 cites W4211100568 @default.
- W4234784734 doi "https://doi.org/10.31829/2691-5391/jhp2020-3(1)-104" @default.
- W4234784734 hasPublicationYear "2020" @default.
- W4234784734 type Work @default.
- W4234784734 citedByCount "0" @default.
- W4234784734 crossrefType "journal-article" @default.
- W4234784734 hasBestOaLocation W42347847341 @default.
- W4234784734 hasConcept C126322002 @default.
- W4234784734 hasConcept C136935669 @default.
- W4234784734 hasConcept C164705383 @default.
- W4234784734 hasConcept C207886595 @default.
- W4234784734 hasConcept C2776336362 @default.
- W4234784734 hasConcept C2776914184 @default.
- W4234784734 hasConcept C2778198053 @default.
- W4234784734 hasConcept C2780185194 @default.
- W4234784734 hasConcept C2780559512 @default.
- W4234784734 hasConcept C71924100 @default.
- W4234784734 hasConcept C78085059 @default.
- W4234784734 hasConceptScore W4234784734C126322002 @default.
- W4234784734 hasConceptScore W4234784734C136935669 @default.
- W4234784734 hasConceptScore W4234784734C164705383 @default.
- W4234784734 hasConceptScore W4234784734C207886595 @default.
- W4234784734 hasConceptScore W4234784734C2776336362 @default.
- W4234784734 hasConceptScore W4234784734C2776914184 @default.
- W4234784734 hasConceptScore W4234784734C2778198053 @default.
- W4234784734 hasConceptScore W4234784734C2780185194 @default.
- W4234784734 hasConceptScore W4234784734C2780559512 @default.
- W4234784734 hasConceptScore W4234784734C71924100 @default.
- W4234784734 hasConceptScore W4234784734C78085059 @default.
- W4234784734 hasLocation W42347847341 @default.
- W4234784734 hasOpenAccess W4234784734 @default.
- W4234784734 hasPrimaryLocation W42347847341 @default.
- W4234784734 hasRelatedWork W2051712573 @default.
- W4234784734 hasRelatedWork W2091139515 @default.
- W4234784734 hasRelatedWork W2319805938 @default.
- W4234784734 hasRelatedWork W2355594703 @default.
- W4234784734 hasRelatedWork W2900216660 @default.
- W4234784734 hasRelatedWork W3032375464 @default.
- W4234784734 hasRelatedWork W3033076790 @default.
- W4234784734 hasRelatedWork W3155674270 @default.
- W4234784734 hasRelatedWork W3187572025 @default.
- W4234784734 hasRelatedWork W4234784734 @default.
- W4234784734 isParatext "false" @default.
- W4234784734 isRetracted "false" @default.
- W4234784734 workType "article" @default.